Neurogene, Inc. is a clinical-stage biotechnology company, which engages in the development of product portfolio of genetic medicines for rare neurological diseases. The company was founded in May 2007 and is headquartered in New York, NY.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
107
Frequently Asked Questions
What is Market Cap of Neurogene Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Neurogene Inc market cap is $272M.
What is the 52-week high for Neurogene Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Neurogene Inc 52 week high is $37.27 as of February 05, 2026.
What is the 52-week low for Neurogene Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Neurogene Inc 52 week low is $6.88 as of February 05, 2026.
What is Neurogene Inc stock price today?
Neurogene Inc stock price today is $17.18.
What was Neurogene Inc stock price yesterday?
Neurogene Inc stock price yesterday was $17.56.
What is the PE ratio of Neurogene Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Neurogene Inc’s P/E ratio is -3.88.
What is the Price-to-Book ratio of Neurogene Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Neurogene Inc P/B ratio is 0.9559.
What is the 50-day moving average of Neurogene Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Neurogene Inc 50-day moving average is $19.45.
